STOCK TITAN

Morgan Stanley SEC Filings

MS NYSE

Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.

Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.

The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.

On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.

Rhea-AI Summary

Morgan Stanley Finance LLC is offering principal-at-risk, contingent income auto-callable notes linked to Meta Platforms Class A common stock. The securities have a $1,000 stated principal amount, a contingent coupon at an annual rate of 11.50%, automatic early redemption triggers tied to the underlier, and a maturity date of June 4, 2027. Coupons are paid only if the underlier meets the coupon barrier on observation dates; principal repayment at maturity depends on the final level relative to a downside threshold set at 68% of the initial level. All payments are subject to the credit risk of Morgan Stanley and the securities do not participate in upside of the underlier.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley files a preliminary pricing supplement for Principal at Risk, contingent income auto-callable securities with a stated principal amount of $1,000 per security and a contingent coupon at an annual rate of 10.50%. The securities reference the Nasdaq-100® Technology Sector Index℠ and the S&P 500® Index and feature automatic early redemption opportunities and downside exposure tied to an 80% barrier. The estimated value on the pricing date is approximately $968.70 per security. The notes pay contingent coupons only if both underliers meet coupon barrier levels on observation dates, may be automatically redeemed on specified redemption determination dates, and pay at maturity either principal or a reduced amount based on the worst performing underlier.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC is offering Trigger Absolute Return Step Securities due April 30, 2031, fully and unconditionally guaranteed by Morgan Stanley, linked to a weighted basket of international indices. Each Security has an Issue Price of $10.00 and an estimated Trade Date value of approximately $9.340. The Securities provide a ranged Step Return of 37.00% to 42.00% if the Final Basket Level is greater than or equal to the Step Barrier (100), a Contingent Absolute Return if the Final Basket Level is below the Step Barrier but at or above the Downside Threshold (75), and full downside exposure to the Basket Return if the Final Basket Level is below the Downside Threshold. The Trade Date is April 28, 2026, Settlement April 30, 2026, Final Valuation Date April 28, 2031, and Maturity April 30, 2031. These are unsecured, unsubordinated debt obligations; payments, including any principal repayment, are subject to Morgan Stanley’s credit risk. The Securities do not pay interest and may result in significant or total loss of principal at maturity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Morgan Stanley Finance LLC is offering Trigger Step Securities due April 30, 2031, fully guaranteed by Morgan Stanley, with returns linked to the least performing of the S&P 500® and the EURO STOXX 50®. The securities pay no interest and have an Issue Price of $10.00 per security. If the Final Level of each underlying is at or above its Step Barrier (100% of the Initial Level), holders receive the greater of the Step Return (illustrative range 63.00%–68.00%) or the underlying return of the least performing index. If either underlying is below its Downside Threshold (75% of its Initial Level) on the Final Valuation Date, the payment at maturity will reflect the full negative return of the least performing underlying, and investors can lose a significant portion or all of principal. Payments are subject to MSFL’s and Morgan Stanley’s credit risk. Key dates: Trade Date April 28, 2026; Settlement April 30, 2026; Final Valuation Date April 28, 2031; Maturity April 30, 2031 (subject to postponement).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC is offering Capped Leveraged Basket-Linked Notes (guaranteed by Morgan Stanley) that return on a weighted basket of five international equity indices. The notes have an Upside Participation Rate of 300%, an Initial Basket Level of 100 and a Cap Level expected between 109.50% and 111.17%, producing a Maximum Settlement Amount expected between $1,285.00 and $1,335.10 per $1,000 face amount. The estimated value on the trade date is approximately $987.70 per note. If the Final Basket Level is below the Initial Basket Level, the cash payment at maturity will be reduced proportionally and investors could lose some or all of their principal. All payments are subject to the issuer’s and guarantor’s credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Co-President Daniel A. Simkowitz reported an insider transaction involving the company’s common stock. He made a bona fide gift of 8,000 shares and completed an open-market sale of 14,690 shares at a weighted average price of $189.2435 per share. Following these transactions, he directly holds 365,802.079 shares of Morgan Stanley common stock and has an additional 1,805.331 shares held indirectly through a 401(k) Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Daniel A. Simkowitz submitted a Form 144 notice relating to a proposed sale of 32,968 shares of Common stock. The filing shows a disposition dated 01/30/2026 with an aggregate amount of $6,020,312.85. The securities are identified as employee stock unit award(s) with a date of 02/19/2026 and are listed as issuer-side securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Morgan Stanley Co-President Andrew M. Saperstein reported selling 51,668 shares of Morgan Stanley common stock in a series of open-market transactions on April 16, 2026. The sales were executed at weighted average prices, with disclosed ranges generally between $186.77 and $192.34 per share.

After these transactions, Saperstein directly holds 282,142.385 shares of Morgan Stanley common stock, so the filing reflects a partial reduction rather than a full exit from his equity position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Morgan Stanley Chief Financial Officer Sharon Yeshaya reported bona fide gifts of 18,344 shares of Common Stock on 2026-04-16. The transfers consisted of 9,172 shares from her direct holdings and 9,172 shares through an entity described as an LLC on behalf of a trust.

Following these gifts, Yeshaya directly holds 142,487.2 shares of Morgan Stanley Common Stock and indirectly holds 9,172 shares via the LLC/trust structure. Gift transactions are non-market dispositions with no sale proceeds, so they do not represent open-market buying or selling activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Morgan Stanley Chief Client Officer Mandell Crawley reported multiple transactions in Morgan Stanley Common Stock. On April 16, 2026, he completed open-market sales totaling 16,129 shares at weighted average prices around $187–$189 per share, executed across several price ranges.

In a separate transaction the same day, Crawley made a bona fide gift of 1,053 shares of Common Stock. Following these sales and the gift, he directly holds 61,475.888 shares of Morgan Stanley Common Stock, according to the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Morgan Stanley (MS) SEC filings are available on StockTitan?

StockTitan tracks 3305 SEC filings for Morgan Stanley (MS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Morgan Stanley (MS)?

The most recent SEC filing for Morgan Stanley (MS) was filed on April 17, 2026.